Intravenous Acetaminophen Use With Bariatric Surgery on Morbidly Obese Patients

Stopped early · Not applicable · Has a placebo group

Conditions studied: Obesity, Pain

In brief

Bariatric patients usually require the use of either intravenous or oral opioid medications. The use of opioids, however, is often associated with side-effects such as nausea, sedation pruritus, urinary retention and respiratory depression with often delay patient discharge. This study makes use of intravenous acetaminophen , a non-opioid analgesic preoperatively to determine if this will decrease the use of opioids post-operatively for pain management in morbidly obese patients undergoing laparoscopic bariatric surgery.

Key facts

Study ID

NCT01527942

Run by

Trinity Health Of New England

People needed

34

Starts

2012-03-01

Expected to finish

2013-07-01

Last updated by the study team

2015-12-17

Who can join

Age: 20 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Morbidly Obese and body mass index (BMI) of 35
• Between ages 20-17
• Candidates for Laparoscopic Bariatric Surgery

You may not qualify if…

• know hypersensitivity to acetaminophen or opioids
• impairment in liver function
• renal dysfunction
• mental retardation

Where it is running

• Saint Francis Hospital — Hartford, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.